• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荚膜、脂蛋白和定植时间对肺炎链球菌鼻咽定植既往者保护性免疫的贡献。

Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation.

机构信息

Centre for Respiratory Research, Department of Medicine, UCL, London, United Kingdom.

出版信息

Vaccine. 2012 Jun 22;30(30):4453-9. doi: 10.1016/j.vaccine.2012.04.080. Epub 2012 May 3.

DOI:10.1016/j.vaccine.2012.04.080
PMID:22561489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3657162/
Abstract

Live attenuated vaccines have been proposed as a strategy to induce protective immunity against infectious diseases. Recent data have demonstrated that nasopharyngeal colonisation with Streptococcus pneumoniae induces protective immunity against subsequent invasive infection, suggesting nasal vaccination with live attenuated bacteria could be a preventative strategy. However the bacterial factors affecting the strength of this adaptive immune response remain unclear. In a direct comparison with the parent wild-type strain, we found that colonisation with bacteria lacking either capsule or surface lipoproteins led to significantly diminished protection. Immunity after colonisation was not dependent on serum IgG to capsular antigens. Colonisation density and duration was reduced for all the non-protective strains, suggesting that protective immunity maybe related to the extent of nasopharyngeal bacterial exposure. To investigate this hypothesis, we utilised an auxotrophic bacterial Δpab strain where duration of colonisation could be controlled by supply and removal of para-amino-benzoic acid (PABA) to mouse drinking water. Supporting colonisation with the Δpab strain for 5 days with PABA led to a faster serum antibody response compared to colonisation for less than 48 h. This enhanced immunogenicity was associated with a trend towards protection. The data presented here aid our understanding of why only certain live attenuated strains are able to function as effective vaccines, and may be valuable in informing the constituents of future live attenuated vaccines.

摘要

减毒活疫苗被提议作为一种诱导针对传染病的保护性免疫的策略。最近的数据表明,鼻咽部定植肺炎链球菌可诱导对随后侵袭性感染的保护性免疫,这表明用减毒活细菌进行鼻内接种可能是一种预防策略。然而,影响这种适应性免疫反应强度的细菌因素仍不清楚。在与亲本野生型菌株的直接比较中,我们发现,定植缺乏荚膜或表面脂蛋白的细菌会导致保护作用显著减弱。定植后的免疫并不依赖于针对荚膜抗原的血清 IgG。所有非保护性菌株的定植密度和持续时间都降低了,这表明保护性免疫可能与鼻咽部细菌暴露的程度有关。为了研究这一假设,我们利用了一种营养缺陷型细菌Δpab 菌株,通过向小鼠饮用水中添加或去除对氨基苯甲酸(PABA)来控制其定植时间。用 PABA 支持Δpab 菌株定植 5 天可导致比定植不到 48 小时更快的血清抗体反应。这种增强的免疫原性与保护的趋势有关。本研究结果有助于我们了解为什么只有某些减毒活菌株能够作为有效的疫苗发挥作用,并可能有助于为未来的减毒活疫苗提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/c2a6c2bd3859/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/d032ea51e68d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/cf3c3231acf0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/635ab2e749ce/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/c048bee8e9e2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/2f637d6b4f59/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/eea9490d8ea7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/c2a6c2bd3859/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/d032ea51e68d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/cf3c3231acf0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/635ab2e749ce/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/c048bee8e9e2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/2f637d6b4f59/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/eea9490d8ea7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d372/3657162/c2a6c2bd3859/gr7.jpg

相似文献

1
Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation.荚膜、脂蛋白和定植时间对肺炎链球菌鼻咽定植既往者保护性免疫的贡献。
Vaccine. 2012 Jun 22;30(30):4453-9. doi: 10.1016/j.vaccine.2012.04.080. Epub 2012 May 3.
2
The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.肺炎球菌鼻咽定植的免疫效果;预防未来定植和致命性侵袭性疾病。
Immunobiology. 2010 Apr;215(4):251-63. doi: 10.1016/j.imbio.2009.12.004. Epub 2009 Dec 28.
3
Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation.针对鼻咽定植的抗体和 Th17 细胞反应对侵袭性肺炎链球菌肺炎的保护作用。
PLoS One. 2011;6(10):e25558. doi: 10.1371/journal.pone.0025558. Epub 2011 Oct 7.
4
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.条件性毒力减弱肺炎链球菌 Δpab 株感染诱导针对保守蛋白抗原的抗体,但不能预防与异源株的全身感染。
Infect Immun. 2011 Dec;79(12):4965-76. doi: 10.1128/IAI.05923-11. Epub 2011 Sep 26.
5
Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.黏膜和全身免疫接种新型减毒肺炎球菌候选疫苗可在小鼠中提供针对肺炎链球菌的血清型非依赖性保护。
Vaccine. 2014 Jul 16;32(33):4179-88. doi: 10.1016/j.vaccine.2014.05.019. Epub 2014 Jun 2.
6
Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With Deletion.血清型非依赖型肺炎链球菌侵袭性感染的活疫苗缺失株保护作用
Front Immunol. 2019 May 29;10:1212. doi: 10.3389/fimmu.2019.01212. eCollection 2019.
7
Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG.尽管全细胞 ELISA 显示出显著的交叉反应 IgG,但在小鼠肺炎链球菌鼻咽定植后,针对异源菌株引起的侵袭性肺炎缺乏交叉保护。
Vaccine. 2013 May 1;31(19):2328-32. doi: 10.1016/j.vaccine.2013.03.013. Epub 2013 Mar 21.
8
Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.肺炎球菌荚膜多糖 3 型人源单克隆抗体的分离与鉴定
Microbiol Spectr. 2021 Dec 22;9(3):e0144621. doi: 10.1128/Spectrum.01446-21. Epub 2021 Nov 10.
9
Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.鼻腔接种脂蛋白可预防肺炎球菌定植。
Front Immunol. 2018 Oct 18;9:2405. doi: 10.3389/fimmu.2018.02405. eCollection 2018.
10
Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.人类对肺炎球菌的天然获得性免疫依赖于针对蛋白质抗原的抗体。
PLoS Pathog. 2017 Jan 30;13(1):e1006137. doi: 10.1371/journal.ppat.1006137. eCollection 2017 Jan.

引用本文的文献

1
A Trivalent Live Vaccine Elicits Cross-Species Protection Against Acute Otitis Media in a Murine Model.一种三价活疫苗在小鼠模型中引发针对急性中耳炎的跨物种保护作用。
Vaccines (Basel). 2024 Dec 19;12(12):1432. doi: 10.3390/vaccines12121432.
2
The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi.定植性肺炎链球菌在 13 价肺炎球菌结合疫苗(PCV13)引入城市马拉维后,其代谢、毒力和抗菌药物耐药谱发生改变。
Nat Commun. 2023 Nov 17;14(1):7477. doi: 10.1038/s41467-023-43160-y.
3
Corrected and Republished from: "A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Challenge".

本文引用的文献

1
Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice.肺炎链球菌 pep27 突变体作为一种活疫苗,可在小鼠中提供针对血清型非依赖性的保护。
Vaccine. 2012 Mar 2;30(11):2008-19. doi: 10.1016/j.vaccine.2011.11.073. Epub 2011 Dec 7.
2
Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation.针对鼻咽定植的抗体和 Th17 细胞反应对侵袭性肺炎链球菌肺炎的保护作用。
PLoS One. 2011;6(10):e25558. doi: 10.1371/journal.pone.0025558. Epub 2011 Oct 7.
3
Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.
源自:《一种新型多抗原肺炎球菌疫苗可抵御致命攻击》,经修正后重新发表
Infect Immun. 2022 Jan 25;90(1):e0084618a. doi: 10.1128/IAI.00846-18a. Epub 2018 Dec 10.
4
Protective Effect of Nasal Colonisation with and Strains against Recolonisation and Invasive Infection.用[具体菌株名称1]和[具体菌株名称2]菌株进行鼻腔定植对再定植和侵袭性感染的保护作用。
Vaccines (Basel). 2021 Mar 15;9(3):261. doi: 10.3390/vaccines9030261.
5
Extracellular Pneumococcal Serine Proteases Affect Nasopharyngeal Colonization.细胞外肺炎链球菌丝氨酸蛋白酶影响鼻咽定植。
Front Cell Infect Microbiol. 2021 Feb 15;10:613467. doi: 10.3389/fcimb.2020.613467. eCollection 2020.
6
Disruption of the and Genes Attenuates Virulence: Towards the Development of a Live Attenuated Vaccine Candidate.[具体基因名称]和[具体基因名称]基因的破坏减弱了[病毒名称]的毒力:迈向减毒活疫苗候选株的开发。 (你提供的原文中部分基因名称等信息缺失,以上是根据格式要求给出的大致翻译,实际需补充完整准确信息)
Vaccines (Basel). 2020 Apr 15;8(2):187. doi: 10.3390/vaccines8020187.
7
Intranasal Immunization with the Commensal Confers Protective Immunity against Pneumococcal Lung Infection.鼻腔免疫共生菌可提供针对肺炎链球菌肺部感染的保护免疫。
Appl Environ Microbiol. 2019 Mar 6;85(6). doi: 10.1128/AEM.02235-18. Print 2019 Mar 15.
8
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Challenge.一种新型多抗原肺炎球菌疫苗可预防致死性挑战。
Infect Immun. 2019 Feb 21;87(3). doi: 10.1128/IAI.00846-18. Print 2019 Mar.
9
Antibodies Reactive to Commensal Show Cross-Reactivity With Virulent Serotypes.与共生菌反应的抗体与毒力血清型显示交叉反应。
Front Immunol. 2018 Apr 16;9:747. doi: 10.3389/fimmu.2018.00747. eCollection 2018.
10
Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.人类对肺炎球菌的天然获得性免疫依赖于针对蛋白质抗原的抗体。
PLoS Pathog. 2017 Jan 30;13(1):e1006137. doi: 10.1371/journal.ppat.1006137. eCollection 2017 Jan.
条件性毒力减弱肺炎链球菌 Δpab 株感染诱导针对保守蛋白抗原的抗体,但不能预防与异源株的全身感染。
Infect Immun. 2011 Dec;79(12):4965-76. doi: 10.1128/IAI.05923-11. Epub 2011 Sep 26.
4
Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice.Nod2 识别溶菌酶消化的肽聚糖可促进巨噬细胞募集并清除肺炎链球菌定植小鼠中的肺炎链球菌。
J Clin Invest. 2011 Sep;121(9):3666-76. doi: 10.1172/JCI57761. Epub 2011 Aug 15.
5
The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia.NLRP3 炎性小体被肺炎球菌溶血素变体差异激活,并有助于肺炎球菌性肺炎的宿主防御。
J Immunol. 2011 Jul 1;187(1):434-40. doi: 10.4049/jimmunol.1003143. Epub 2011 Jun 6.
6
Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling.细菌抗原的脂质基序通过 TLR2 信号介导免疫应答。
PLoS One. 2011;6(5):e19781. doi: 10.1371/journal.pone.0019781. Epub 2011 May 17.
7
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.肺炎球菌结合疫苗对英格兰特定血清型携带和侵袭性疾病的影响:一项横断面研究。
PLoS Med. 2011 Apr;8(4):e1001017. doi: 10.1371/journal.pmed.1001017. Epub 2011 Apr 5.
8
T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization.基于 T(H)17 的疫苗设计预防肺炎链球菌定植。
Cell Host Microbe. 2011 Feb 17;9(2):158-65. doi: 10.1016/j.chom.2011.01.007.
9
Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteins.一种基于多重微球的免疫分析方法的开发,用于同时检测针对 17 种肺炎球菌蛋白的抗体。
Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):521-6. doi: 10.1007/s10096-010-1113-x. Epub 2010 Nov 18.
10
Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.肺炎球菌溶血素激活 NLRP3 炎性小体并促进促炎细胞因子的产生,而不依赖于 TLR4。
PLoS Pathog. 2010 Nov 11;6(11):e1001191. doi: 10.1371/journal.ppat.1001191.